Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2012-12-20 Regulatory Filings
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Securities and Exchange Commission requesting acceleration of the effective date of a Registration Statement on Form S-3. It is a formal communication related to a regulatory filing process, specifically about the timing of the effectiveness of a registration statement. The document does not contain financial data, report content, or detailed disclosures itself, but rather is a procedural request. The length is short (1905 characters), and it is clearly an announcement/request related to a filing rather than the filing or report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2012-12-20 English
Regulatory Filings 2012
Regulatory Filings Classification · 100% confidence The document is a correspondence letter addressed to the SEC Division of Corporation Finance regarding Amendment No. 2 to a Registration Statement on Form S-3 filed by OraSure Technologies, Inc. It discusses legal opinions related to the registration statement, specifically about governing law for rights, warrants, and units. The content is a response to SEC staff comments and clarifications about legal matters related to a registration statement filing. There is no financial data, earnings information, or report content. The document is short (4385 characters) and is clearly a regulatory correspondence related to a registration statement amendment. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other categories.
2012-12-19 English
AMENDMENT NO. 2 TO FORM S-3
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 2 to Form S-3 filed with the SEC, which is a registration statement under the Securities Act of 1933. It details the registration of securities for public offering, including common stock, preferred stock, warrants, rights, debt securities, and units, with a total offering price not to exceed $200 million. The document includes information about the registration fee, the types of securities to be offered, and the terms of the offering. This type of filing is related to capital raising activities and financing updates rather than financial performance reports, management changes, or other categories. Therefore, it fits the definition of a Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not merely an announcement or a brief summary, supporting a high confidence level.
2012-12-17 English
Regulatory Filings 2012
Regulatory Filings
2012-12-11 English
AMENDMENT NO. 1 TO FORM S-3
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-3 Registration Statement filed with the SEC. It is a registration statement under the Securities Act of 1933 for the purpose of registering securities for sale, including common stock, preferred stock, warrants, rights, debt securities, and units. The document includes details about the registration fee, offering price, and legal disclaimers typical of a securities registration statement. It is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Confidence is high given the clear identification as an SEC Form S-3 amendment related to securities registration and offering.
2012-11-30 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes a press release announcing a new senior vice president and a marketing campaign launch. There are no financial statements or detailed financial data included. The document is relatively short (2484 characters) and primarily serves as a regulatory announcement of a corporate event rather than a detailed report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2012-11-28 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.